ICU Medical to Present at the J.P. Morgan 41st Annual Healthcare Conference
ICU Medical (Nasdaq: ICUI), a leader in medical product development, has announced its participation in the J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ICU Medical (Nasdaq: ICUI), a leader in medical product development, has announced its participation in the J.P. Morgan 41st Annual Healthcare Conference in San Francisco from January 9-12, 2023. The company's presentation is scheduled for January 11, 2023, at 1:30 p.m. PST (4:30 p.m. EST) and will be available via a live webcast on its website. ICU Medical specializes in infusion systems and critical care products, aiming to deliver quality and innovation to clinical customers globally. More information can be found on their website.
Details
News Market Reaction – ICUI
The recorded move for ICUI in the trading session of this news was -1.47%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN CLEMENTE, Calif., Dec. 19, 2022 (GLOBE NEWSWIRE) -- ICU Medical, (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the J.P. Morgan 41st Annual Healthcare Conference, being held in San Francisco, CA, January 9-12, 2023. ICU Medical’s presentation will be on Wednesday, January 11, 2023 at 1:30 p.m. PST (4:30 p.m. EST).
The presentation will be webcast live and can be accessed by going to the Company’s website at http://www.icumed.com, clicking on the Investors tab and clicking on the Event Calendar tab. The webcast will also be available by replay.
About ICU Medical
ICU Medical (Nasdaq:ICUI) is a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical can be found at www.icumed.com
CONTACT:
ICU Medical, Inc.
Brian Bonnell, Chief Financial Officer
(949) 366-2183
ICR, Inc.
John Mills, Managing Partner
(646) 277-1254
Source: ICU Medical, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.